Bartlett & Co. LLC Gilead Sciences, Inc. Transaction History

Bartlett & Co. LLC

$6.16 Billion
Q4 2023

A detailed history of Bartlett & Co. LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bartlett & Co. LLC holds 3,466 shares of GILD stock, worth $320,293. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,466

Previous 4,266 18.75%

Holding current value

$320,293

Previous $320,000 12.19%

% of portfolio

0.0%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	SELL	$73.27 - $83.09 $58,616 - $66,472	-800 Reduced 18.75%	3,466 $281,000
Q3 2023 Oct 10, 2023	SELL	$73.94 - $80.67 $30,832 - $33,639	-417 Reduced 8.9%	4,266 $320,000
Q2 2023 Jul 14, 2023	BUY	$76.01 - $86.7 $72,209 - $82,365	950 Added 25.45%	4,683 $361,000
Q1 2023 Apr 06, 2023	BUY	$77.31 - $88.08 $39,350 - $44,832	509 Added 15.79%	3,733 $307,000
Q3 2022 Oct 17, 2022	SELL	$59.54 - $68.01 $9,705 - $11,085	-163 Reduced 4.81%	3,224 $199,000
Q2 2022 Aug 02, 2022	BUY	$57.72 - $65.01 $8,658 - $9,751	150 Added 4.63%	3,387 $209,000
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $17,376 - $21,774	-300 Reduced 8.48%	3,237 $192,000
Q4 2021 Mar 08, 2022	SELL	$64.88 - $73.64 $129,176 - $146,617	-1,991 Reduced 36.02%	3,537 $257,000
Q3 2021 Oct 15, 2021	SELL	$67.69 - $73.03 $101,535 - $109,545	-1,500 Reduced 21.34%	5,528 $386,000
Q2 2021 Jul 19, 2021	SELL	$63.47 - $69.35 $186,601 - $203,888	-2,940 Reduced 29.49%	7,028 $484,000
Q1 2021 Apr 19, 2021	SELL	$60.0 - $68.46 $122,700 - $140,000	-2,045 Reduced 17.02%	9,968 $644,000
Q4 2020 Jan 20, 2021	SELL	$56.65 - $64.55 $10.1 Million - $11.5 Million	-177,512 Reduced 93.66%	12,013 $700,000
Q3 2020 Oct 20, 2020	SELL	$62.1 - $78.08 $1.45 Million - $1.82 Million	-23,360 Reduced 10.97%	189,525 $12 Million
Q2 2020 Aug 03, 2020	SELL	$72.34 - $84.0 $1.51 Million - $1.75 Million	-20,825 Reduced 8.91%	212,885 $16.4 Million
Q1 2020 May 07, 2020	SELL	$62.63 - $80.22 $2,129 - $2,727	-34 Reduced 0.01%	233,710 $17.5 Million
Q3 2019 Nov 04, 2019	SELL	$62.51 - $69.0 $181,904 - $200,790	-2,910 Reduced 1.23%	233,744 $14.8 Million
Q2 2019 Jul 24, 2019	SELL	$61.87 - $69.38 $314,670 - $352,866	-5,086 Reduced 2.1%	236,654 $16 Million
Q1 2019 Apr 23, 2019	BUY	$62.53 - $70.05 $1.84 Million - $2.06 Million	29,435 Added 13.86%	241,740 $0
Q4 2018 Jan 23, 2019	SELL	$60.54 - $79.0 $4.82 Million - $6.29 Million	-79,563 Reduced 27.26%	212,305 $13.3 Million
Q3 2018 Oct 15, 2018	BUY	$71.28 - $78.92 $855 - $947	12 Added 0.0%	291,868 $22.5 Million
Q2 2018 Jul 31, 2018	SELL	$64.88 - $75.68 $696,292 - $812,197	-10,732 Reduced 3.55%	291,856 $20.7 Million
Q1 2018 Apr 25, 2018	BUY	$72.84 - $88.8 $415,115 - $506,071	5,699 Added 1.92%	302,588 $22.8 Million
Q4 2017 Jan 19, 2018	SELL	$71.15 - $83.52 $369,268 - $433,468	-5,190 Reduced 1.72%	296,889 $21.3 Million
Q3 2017 Oct 23, 2017	BUY	$72.11 - $85.47 $21.8 Million - $25.8 Million	302,079	302,079 $24.5 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. LLC with notifications on news.

Account